CIBC Private Wealth Group’s Ligand Pharmaceuticals LGND Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$9.09K Sell
80
-123
-61% -$14K ﹤0.01% 2286
2025
Q1
$19.6K Buy
203
+43
+27% +$4.16K ﹤0.01% 2001
2024
Q4
$17.7K Hold
160
﹤0.01% 2108
2024
Q3
$16K Hold
160
﹤0.01% 2254
2024
Q2
$13.9K Hold
160
﹤0.01% 2173
2024
Q1
$11.8K Buy
+160
New +$11.8K ﹤0.01% 2217
2022
Q4
Sell
-19,302
Closed -$1.04M 904
2022
Q3
$1.04M Hold
19,302
﹤0.01% 584
2022
Q2
$1.07M Hold
19,302
﹤0.01% 587
2022
Q1
$1.36M Sell
19,302
-27
-0.1% -$1.9K ﹤0.01% 590
2021
Q4
$1.86M Sell
19,329
-186
-1% -$17.9K ﹤0.01% 534
2021
Q3
$1.7M Sell
19,515
-3,092
-14% -$269K ﹤0.01% 532
2021
Q2
$1.85M Sell
22,607
-48
-0.2% -$3.93K ﹤0.01% 544
2021
Q1
$2.15M Buy
22,655
+1,545
+7% +$147K 0.01% 529
2020
Q4
$1.31M Sell
21,110
-2,917
-12% -$181K ﹤0.01% 579
2020
Q3
$1.43M Buy
24,027
+35
+0.1% +$2.08K ﹤0.01% 499
2020
Q2
$1.67M Sell
23,992
-7,327
-23% -$511K 0.01% 399
2020
Q1
$1.42M Sell
31,319
-4,524
-13% -$205K 0.01% 463
2019
Q4
$2.33M Sell
35,843
-75,009
-68% -$4.88M 0.01% 449
2019
Q3
$6.88M Sell
110,852
-5,648
-5% -$351K 0.02% 318
2019
Q2
$8.3M Sell
116,500
-6,505
-5% -$463K 0.03% 314
2019
Q1
$9.65M Buy
123,005
+12,238
+11% +$960K 0.04% 280
2018
Q4
$9.38M Buy
110,767
+14,143
+15% +$1.2M 0.04% 267
2018
Q3
$16.5M Sell
96,624
-15,669
-14% -$2.68M 0.06% 232
2018
Q2
$14.5M Sell
112,293
-124,927
-53% -$16.1M 0.06% 241
2018
Q1
$24.4M Buy
237,220
+1,848
+0.8% +$190K 0.11% 184
2017
Q4
$20.1M Buy
235,372
+4,798
+2% +$410K 0.09% 204
2017
Q3
$19.6M Buy
230,574
+4,072
+2% +$346K 0.09% 195
2017
Q2
$17.2M Sell
226,502
-1,754
-0.8% -$133K 0.11% 154
2017
Q1
$15.1M Sell
228,256
-1,888
-0.8% -$125K 0.09% 159
2016
Q4
$14.6M Buy
230,144
+396
+0.2% +$25.1K 0.1% 162
2016
Q3
$14.6M Sell
229,748
-39,372
-15% -$2.51M 0.1% 158
2016
Q2
$20M Buy
+269,120
New +$20M 0.15% 131